In NEJM: Dose Escalation Best Approach for Sickle Cell Med in Africa

Post Date: June 25, 2020 | Publish Date: June 25, 2020


Russell Ware, MD, PhD

“The study shows clearly that the optimized dosing strategy for hydroxyurea, though it requires more effort than a fixed-dose treatment regimen, results in far better outcomes for children with sickle cell anemia,”

— Russell Ware, MD, PhD

Publication Information

Original Title:Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
Published in:New England Journal of Medicine
Publish date:June 25, 2020

Read the Study

About this blog

The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.